Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The formatting and display of sponsor information and study-section labels were updated (e.g., 'Intervention/Treatment' vs 'Intervention / Treatment'), and versioning details like 'Revision: v3.6.0' were introduced.
    Difference
    1%
    Check dated 2026-06-13T17:33:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the study record display.
    Difference
    0.1%
    Check dated 2026-06-06T14:01:04.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a new revision tag Revision: v3.5.4 in place of the previous Revision: v3.5.3. This indicates a minor update to the study record's documentation on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-05-16T08:30:47.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A small change in the page’s site revision/version indicator, updating it from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T16:53:55.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:41:33.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces v3.4.3 on the page; no evident changes to study details or related information.
    Difference
    0.1%
    Check dated 2026-03-19T23:40:28.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.